A frequent alteration of p53 gene in carcinoma in adenoma of colon.

In general, colorectal carcinoma is thought to originate mainly from adenoma, and this pathway is called the adenoma-carcinoma sequence. Carcinoma in adenoma is an appropriate model for analysis of this mechanism, because adenoma and carcinoma tissues coexist in the same polyp and the carcinoma is thought to have originated from the surrounding adenoma. Expression of the p53 protein was analyzed in 36 cases of carcinoma in adenoma in the colon by immunohistochemistry using an anti-human p53 monoclonal antibody (PAb1801). Alterations of the p53 gene were analyzed by the polymerase chain reaction for microanalysis of normal mucosa, adenoma, and carcinoma from histological slides. Mutations were assessed by the polymerase chain reaction-single strand conformation polymorphism analysis and identified by DNA sequencing in some cases. Loss of heterozygosity was studied by polymerase chain reaction-restriction fragment length polymorphism analysis. Positive staining for p53 was detected in three (8%) of 37 adenomas and 20 (53%) of 38 focal carcinomas. One (7%) of 15 adenomas with mild dysplasia, three (14%) of 22 adenomas with moderate dysplasia, and 16 (42%) of 38 focal carcinomas had a mutation in exon 5 through exon 8 of the p53 gene. As for allelic loss in the p53 gene locus, only one adenoma with moderate dysplasia had loss of heterozygosity, whereas six (40%) of 15 focal carcinomas had loss of heterozygosity. Of those tumors (3 of 37 adenomas and 20 of 38 focal carcinomas) that reacted with PAb1801, 78% (18 of 23) showed genetic alterations. Among 52 tumors which showed negative staining, five tumors had a p53 mutation and four of them were nonsense mutations. Putting all of these results together, 71% (24 of 34) of the cases underwent p53 gene and protein alterations during the conversion from adenoma to focal carcinoma. These data clearly indicate that genetic alterations of p53 are involved mainly in the malignant transformation from adenoma to focal carcinoma in colon carcinogenesis. In addition, some cases show heterogeneity of the p53 gene in carcinoma in adenoma of the colon. There may be other pathways than p53 responsible for malignant change in the colon.

[1]  T. Soussi,et al.  Structural aspects of the p53 protein in relation to gene evolution: a second look. , 1996, Journal of molecular biology.

[2]  D. Louis,et al.  Accumulation of wild type p53 protein in human astrocytomas. , 1993, Cancer research.

[3]  G. Capellá,et al.  Genetic heterogeneity of the c-K-ras locus in colorectal adenomas but not in adenocarcinomas. , 1993, Journal of the National Cancer Institute.

[4]  M. Imamura,et al.  Loss of 17p, mutation of the p53 gene, and overexpression of p53 protein in esophageal squamous cell carcinomas. , 1993, Cancer research.

[5]  D. Louis,et al.  Comparative Study of p53 Gene and Protein Alterations in Human Astrocytic Tumors , 1993, Journal of neuropathology and experimental neurology.

[6]  Takesada Mori,et al.  p53 Gene Mutations Associated with Anaplastic Transformation of Human Thyroid Carcinomas , 1992, Japanese journal of cancer research : Gann.

[7]  N. Nadon,et al.  Polymerase chain reaction microanalysis of tumors from stained histological slides. , 1992, Oncogene.

[8]  M. Inoue,et al.  Alterations of the p53 gene in human primary cervical carcinoma with and without human papillomavirus infection. , 1992, Cancer research.

[9]  M. Seki,et al.  Genetic changes of both p53 alleles associated with the conversion from colorectal adenoma to early carcinoma in familial adenomatous polyposis and non-familial adenomatous polyposis patients. , 1992, Cancer research.

[10]  川崎 靖仁 Immunohistochemical study of p53 expression in microwave-fixed, paraffin embedded sections of colorectal carcinoma and adenoma , 1992 .

[11]  J. Minna,et al.  Expression of mutant p53 proteins in lung cancer correlates with the class of p53 gene mutation. , 1992, Oncogene.

[12]  D. Schaid,et al.  Expression of p53 and 17p allelic loss in colorectal carcinoma. , 1992, Cancer research.

[13]  B. Levin Screening sigmoidoscopy for colorectal cancer. , 1992, The New England journal of medicine.

[14]  K. Kinzler,et al.  Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer , 1992, Molecular and cellular biology.

[15]  T. Mikkelsen,et al.  Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.

[16]  Y. Miyoshi,et al.  Immunohistochemical study of p53 expression in microwave-fixed, paraffin-embedded sections of colorectal carcinoma and adenoma. , 1992, American journal of clinical pathology.

[17]  Thierry Soussi,et al.  TP53 tumor suppressor gene: A model for investigating human mutagenesis , 1992, Genes, chromosomes & cancer.

[18]  P. Quirke,et al.  Adenoma screening and colorectal cancer. , 1991, BMJ.

[19]  P. Shaw,et al.  Occurrence of Ki-ras and p53 mutations in primary colorectal tumors. , 1991, Oncogene.

[20]  E. Campo,et al.  Loss of heterozygosity of p53 gene and p53 protein expression in human colorectal carcinomas. , 1991, Cancer research.

[21]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[22]  M. Key,et al.  Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. , 1991, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[23]  J. Milner,et al.  Cotranslation of activated mutant p53 with wild type drives the wild-type p53 protein into the mutant conformation , 1991, Cell.

[24]  Hsu Hey-Chi,et al.  High quality of DNA retrieved for Southern blot hybridization from microwave-fixed, paraffin-embedded liver tissues , 1991 .

[25]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[26]  W. Bodmer,et al.  p53 mutations in colorectal cancer. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[27]  T. Soussi,et al.  Structural aspects of the p53 protein in relation to gene evolution. , 1990, Oncogene.

[28]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[29]  J. Bartek,et al.  Genetic and immunochemical analysis of mutant p53 in human breast cancer cell lines. , 1990, Oncogene.

[30]  D. Lane,et al.  Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. , 1990, The EMBO journal.

[31]  A. Harris,et al.  Increased expression of mutant forms of p53 oncogene in primary lung cancer , 1990, The Lancet.

[32]  Kathleen R. Cho,et al.  Identification of a chromosome 18q gene that is altered in colorectal cancers. , 1990, Science.

[33]  E. Stanbridge Identifying tumor suppressor genes in human colorectal cancer. , 1990, Science.

[34]  F. Collins,et al.  Mutations in the p53 gene occur in diverse human tumour types , 1989, Nature.

[35]  Y. Nakamura,et al.  A BamHI-polymorphism is detected by a genomic p53-clone (pBHP53). , 1989, Nucleic acids research.

[36]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[37]  D. Ledbetter,et al.  Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. , 1989, Science.

[38]  A. Levine,et al.  Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation , 1989, Journal of virology.

[39]  J. Jenkins,et al.  Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells , 1988, Molecular and cellular biology.

[40]  Rotter,et al.  Meth A fibrosarcoma cells express two transforming mutant p53 species. , 1988, Oncogene.

[41]  Y. Nakamura,et al.  Genetic alterations during colorectal-tumor development. , 1988, The New England journal of medicine.

[42]  F. Rilke,et al.  P53 expression in breast cancer , 1988, International journal of cancer.

[43]  A. Levine,et al.  Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life , 1988, Molecular and cellular biology.

[44]  B. Vogelstein,et al.  Clonal analysis of human colorectal tumors. , 1987, Science.

[45]  I. Herskowitz Functional inactivation of genes by dominant negative mutations , 1987, Nature.

[46]  J. Costa,et al.  Prognostic implications of expression of the cellular genes myc, fos, Ha‐ras and Ki‐ras in colon carcinoma , 1987, International journal of cancer.

[47]  A. Balmain,et al.  Immunocytochemical demonstration of p21 ras family oncogene product in normal mucosa and in premalignant and malignant tumours of the colorectum. , 1985, British Journal of Cancer.

[48]  D. Spandidos,et al.  Elevated expression of the human ras oncogene family in premalignant and malignant tumours of the colorectum. , 1984, British Journal of Cancer.

[49]  P. Nowell The clonal evolution of tumor cell populations. , 1976, Science.

[50]  A. Harris,et al.  p53 expression in colorectal adenomas. , 1993, The American journal of pathology.

[51]  M. Pincus,et al.  Conformational effects of selected cancer-related amino acid substitutions in the p53 protein. , 1992, Journal of biomolecular structure & dynamics.

[52]  H. Hsu,et al.  High quality of DNA retrieved for Southern blot hybridization from microwave-fixed, paraffin-embedded liver tissues. , 1991, Journal of virological methods.

[53]  D. Lane,et al.  p53: oncogene or anti-oncogene? , 1990, Genes & development.

[54]  J. Jass,et al.  Do all colorectal carcinomas arise in preexisting adenomas? , 1989, World journal of surgery.

[55]  Bodmer,et al.  p 53 mutations in colorectal cancer ( immunohistokogy / polymerase chain reaction / chemical mismatch cleavage / adenocarcinoma ) , 2022 .